指南与共识头颈技术与安全MRUS

结核性脉络膜炎多模态影像指南:MUV 工作组报告 17

Evidence and Consensus-Based Imaging Guidelines in Tubercular Choroiditis: Multimodal Imaging in Uveitis (MUV) Task Force: Report 17.
指南 / 共识 · Ophthalmol Retina · 2026-06-29

国际多模态葡萄膜炎影像工作组采用改良名义群体法结合文献复习,基于 31 例病例库制定结核性脉络膜炎影像共识。共识明确了结核性匐行样脉络膜炎及脉络膜结核瘤/结核结节的活性、演变与非活性期多模态影像特征,用于诊断、治疗监测及并发症检测。

要点

  • 结核性匐行样脉络膜炎活动期病灶在 ICGA 与 OCTA 上范围常大于临床所见,阅片时应主动扩大评估范围。
  • 脉络膜结核瘤为孤立分叶状肿块,可伴视网膜下液与视网膜新生血管;结核结节为多发小病灶,提示播散性结核。
  • FAF 高自发荧光边缘、OCT 外层视网膜高反射及局灶脉络膜增厚是结核性匐行样脉络膜炎活动性关键征象。

核心结论

  • MUV 影像指南通过系统整合多模态影像特征,扩展了结核性脉络膜炎现有诊断框架,用于疾病特征描述与监测。
  • 共识性推荐提升了表型分类能力,改善了疾病活动性评估,并为评价治疗反应提供了临床相关终点。

研究设计与样本

  • 国际专家委员会主导的共识制定,采用改良名义群体技术,并经文献复习与全体工作组投票进一步完善。
  • 专家成员提供以结核性匐行样脉络膜炎和结核瘤/结核结节为重点的 31 例病例,构成活动期与非活动期纵向随访病例库。
  • 病例库影像包括彩色眼底照相、眼底自发荧光、荧光素眼底血管造影、吲哚菁绿血管造影、OCT 和 OCTA。

关键影像表现/征象

  • 结核性匐行样脉络膜炎活动期病灶表现为黄白色多灶性或匐行样病灶,FAF 示高自发荧光边缘,OCT 示外层视网膜高反射及局灶脉络膜增厚。
  • 吲哚菁绿血管造影与 OCTA 显示的病灶范围常比临床所见更广泛。
  • 脉络膜结核瘤为孤立性分叶状肿块,常伴视网膜下液与视网膜新生血管。
  • 结核结节表现为多发性小病灶,与播散性结核相关。

诊断标准与关键数值

  • 活动期结核性匐行样脉络膜炎的影像特征包括:黄白色多灶性或匐行样病灶、FAF 高自发荧光边缘、OCT 外层视网膜高反射和局灶脉络膜增厚。
  • 脉络膜结核瘤定义为孤立性分叶状肿块,常伴视网膜下液和视网膜新生血管。
  • 结核结节定义为多发性小病灶,与播散性结核相关。
  • 共识性指南确立了运用多模态影像特征进行诊断、治疗反应监测和并发症检测的推荐原则。

临床应用与阅片要点

  • 阅片时对结核性匐行样脉络膜炎应结合 FAF、OCT、ICGA 与 OCTA 综合判断活动性,而非仅依据临床所见病灶范围。
  • 发现孤立分叶状脉络膜肿块伴视网膜下液或视网膜新生血管时,应将脉络膜结核瘤纳入鉴别诊断。
  • 出现多发性小脉络膜病灶时,需警惕播散性结核并建议进一步全身检查。

局限性

  • 病例库来自专家成员提供的经筛选病例,可能存在选择偏倚,未描述连续纳入或随机抽样方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop imaging-based statements and consensus recommendations for the application of multimodal imaging in tubercular choroiditis (TBC).

DESIGN: International expert committee-led consensus agreement using a modified nominal group technique with further refinement from literature review and full task force voting.

PARTICIPANTS: International expert committee of uveitis and retina specialists from the Multimodal Imaging in Uveitis (MUV) task force.

METHODS: The MUV task force convened a group of international experts to develop a set of standardized imaging criteria for TBC. Cases with focus on tubercular serpiginous-like choroiditis (TB SLC) and tuberculomas/tubercles were provided by expert members to develop a review case portfolio of both active and inactive disease with longitudinal follow-up. Cases included color fundus photography, fundus autofluorescence, fundus fluorescein angiography, indocyanine green angiography, OCT, and OCT angiography. The case portfolio was reviewed by all members, and through a structured nominal group technique and guided by a literature review, the group refined descriptive statements characterizing active, evolving, and inactive lesions until consensus was achieved.

MAIN OUTCOME MEASURES: Imaging statements and consensus guidelines describing features of TB SLC and tuberculoma/tubercle in relation to diagnosis, monitoring, and detection of disease complications.

RESULTS: The case portfolio included 31 cases, and the group achieved consensus on defining distinct imaging features of TB SLC and choroidal tuberculomas/tubercles. For TB SLC, key features of active lesions included yellow-white multifocal or placoid lesions with hyperautofluorescent edges on fundus autofluorescence, outer retinal hyperreflectivity, and focal choroidal thickening on OCT. Both indocyanine green angiography and OCT angiography highlight lesions that are often more extensive than those seen clinically. Choroidal tuberculomas were defined as solitary, lobulated masses often associated with subretinal fluid and retinal neovascularization, whereas tubercles appear as multiple small lesions associated with disseminated tuberculosis. Consensus-based guidelines were established to use these multimodal imaging features for diagnosis, monitoring response to treatment, and detecting complications.

CONCLUSIONS: The MUV imaging guidelines for TBC extend existing diagnostic frameworks by systematically integrating multimodal imaging features for disease characterization and monitoring. These consensus-based recommendations enhance phenotypic classification, improve assessment of disease activity, and provide clinically relevant endpoints for evaluating treatment response.

FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

来源:Ophthalmol Retina,查看原文。版权归原作者所有。

引用

  1. Janetos, Agarwal, Biswas, et al. Evidence and Consensus-Based Imaging Guidelines in Tubercular Choroiditis: Multimodal Imaging in Uveitis (MUV) Task Force: Report 17. Ophthalmol Retina. 2026. PMID: 42372875. doi:10.1016/j.oret.2026.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。